GB1129260A - Improvements in or relating to antacid compositions containing silicones - Google Patents

Improvements in or relating to antacid compositions containing silicones

Info

Publication number
GB1129260A
GB1129260A GB53253/66A GB5325366A GB1129260A GB 1129260 A GB1129260 A GB 1129260A GB 53253/66 A GB53253/66 A GB 53253/66A GB 5325366 A GB5325366 A GB 5325366A GB 1129260 A GB1129260 A GB 1129260A
Authority
GB
United Kingdom
Prior art keywords
antacid
granules
aluminium
relating
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB53253/66A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline & French Laboratories Ltd
Original Assignee
Smith Kline & French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline & French Laboratories Ltd filed Critical Smith Kline & French Laboratories Ltd
Publication of GB1129260A publication Critical patent/GB1129260A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/02—Foam dispersion or prevention
    • B01D19/04—Foam dispersion or prevention by addition of chemical substances
    • B01D19/0404—Foam dispersion or prevention by addition of chemical substances characterised by the nature of the chemical substance
    • B01D19/0409—Foam dispersion or prevention by addition of chemical substances characterised by the nature of the chemical substance compounds containing Si-atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB53253/66A 1965-12-06 1966-11-28 Improvements in or relating to antacid compositions containing silicones Expired GB1129260A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA947065 1965-12-06

Publications (1)

Publication Number Publication Date
GB1129260A true GB1129260A (en) 1968-10-02

Family

ID=4142389

Family Applications (1)

Application Number Title Priority Date Filing Date
GB53253/66A Expired GB1129260A (en) 1965-12-06 1966-11-28 Improvements in or relating to antacid compositions containing silicones

Country Status (10)

Country Link
US (1) US3501571A (cg-RX-API-DMAC10.html)
BE (1) BE690679A (cg-RX-API-DMAC10.html)
BR (1) BR6685118D0 (cg-RX-API-DMAC10.html)
DE (1) DE1617800A1 (cg-RX-API-DMAC10.html)
DK (1) DK116020B (cg-RX-API-DMAC10.html)
FR (2) FR6885M (cg-RX-API-DMAC10.html)
GB (1) GB1129260A (cg-RX-API-DMAC10.html)
IL (1) IL26885A (cg-RX-API-DMAC10.html)
NL (1) NL6617127A (cg-RX-API-DMAC10.html)
SE (1) SE348940B (cg-RX-API-DMAC10.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US5458886A (en) * 1993-06-04 1995-10-17 Dow Corning France S.A. Antifoam compositions
DE102012024434A1 (de) * 2012-12-14 2014-06-18 Regalismons S.A. Verstärkung der entschäumenden Wirkung von Polysiloxanen, zugehöriger Zusammensetzungen und Lösungen

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA885974A (en) * 1968-04-02 1971-11-16 Mowatt And Moore Limited Ferrous fumarate capsule and preparation
GB1357737A (en) * 1970-10-09 1974-06-26 Arpic Sa Sustained release pharmaceutical compositions
JPS51123814A (en) * 1975-04-22 1976-10-28 Shin Etsu Chem Co Ltd A process for preparing gradually releasable solid medicines
US4198390A (en) 1979-01-31 1980-04-15 Rider Joseph A Simethicone antacid tablet
ATE51147T1 (de) * 1982-07-27 1990-04-15 Mylan Pharmaceuticals Inc Verfahren zur herstellung einer kombinierten pharmazeutischen zusammensetzung in einer granulaeren heterogenen dosisform mit erhoehter bioverfuegbarkeit.
US4594243A (en) * 1984-07-25 1986-06-10 Nitto Electric Industrial Co., Ltd. Base composition for medicament and pharmaceutical composition for external medication
GB8710965D0 (en) * 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
EP0294933B1 (en) * 1987-05-08 1992-03-11 Smith Kline & French Laboratories Limited Pharmaceutical compositions
WO1990007930A1 (de) * 1989-01-19 1990-07-26 Steigerwald Arzneimittelwerk Gmbh Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
US5275822A (en) * 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
USRE35893E (en) * 1989-10-19 1998-09-08 Valentine Enterprises, Inc. Defoaming composition
DE3937455A1 (de) * 1989-11-10 1991-05-16 Nordmark Arzneimittel Gmbh Antacidatabletten
US6399591B1 (en) * 2000-01-19 2002-06-04 Yung-Shin Pharmaceutical Ind. Co., Ltd. Chargeable pharmaceutical tablets

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2477080A (en) * 1947-07-15 1949-07-26 Michael Reese Res Foundation Antacid preparation
USRE25205E (en) * 1960-10-10 1962-07-24 Silicone composition for the relief of
AU407324B2 (en) * 1962-05-01 1970-10-28 Smith, Kline & French Laboratories Powdered silicone products and processes
FR175F (cg-RX-API-DMAC10.html) * 1964-05-25 1900-01-01

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US5458886A (en) * 1993-06-04 1995-10-17 Dow Corning France S.A. Antifoam compositions
DE102012024434A1 (de) * 2012-12-14 2014-06-18 Regalismons S.A. Verstärkung der entschäumenden Wirkung von Polysiloxanen, zugehöriger Zusammensetzungen und Lösungen
US10617761B2 (en) 2012-12-14 2020-04-14 Regalismons S.A. Compositions and solutions for colon cleansing

Also Published As

Publication number Publication date
DK116020B (da) 1969-12-01
DE1617800A1 (de) 1971-04-08
IL26885A (en) 1970-10-30
SE348940B (cg-RX-API-DMAC10.html) 1972-09-18
FR1515061A (fr) 1968-03-01
NL6617127A (cg-RX-API-DMAC10.html) 1967-06-07
US3501571A (en) 1970-03-17
FR6885M (cg-RX-API-DMAC10.html) 1969-04-21
BR6685118D0 (pt) 1973-12-04
BE690679A (cg-RX-API-DMAC10.html) 1967-06-05

Similar Documents

Publication Publication Date Title
AU473397B2 (en) Fat compositions
ES395327A1 (es) Un procedimiento para la preparacion de composiciones li- quidas tensioactivas.
ES314080A1 (es) Mejoras introducidas en la preparacion de composiciones de silice y alumina.
AU459004B2 (en) Surface treating compositions containing ammonioamidate compounds
GB1182655A (en) Colour Stabilized Compositions containing Alkylated Phenols
AU455335B2 (en) Mixing liquid for silicate cements
CA988658A (en) Compositions for the preparation of cold-bleaching liquors
CA953254A (en) Device for the storage, mixing and dispensing of ingredients
CA970693A (en) Anthelminthic compositions containing thioallophanate compounds
IL37584A (en) Stable nadh compositions and processes for the preparation thereof and reagents containing the same
AU462266B2 (en) Improved cement compositions andthe preparation thereof
CA946083A (en) Organopolysiloxane compositions
IL37212A (en) The preparation of surface-active compositions
AU2799371A (en) Methods for preserving antacid compositions
IE34826L (en) Neriifolin derivatives.
AU463232B2 (en) Emulsifier compositions
CA948022A (en) Compositions of milk chocolate crumbs
IL40082A0 (en) Pharmaceutical compositions containing alpha-bisabolol
AU452653B2 (en) Flowable high filler content silicone composition
IL37460A (en) Stabilized insecticidal compositions containing geranyl phenyl ethers
Roark The thermal decomposition of 7, 8-disilabicyclo [2.2. 2] octa-2, 5-dienes: evidence for the transient existence of silicon-silicon double bonds
GB1236880A (en) Antacid compositions
CA958841A (en) Stabilized compositions containing alkylated p-hydroxyphenylalkyl phosphinates
AU3116171A (en) Mixture composition monitor
GB1106326A (en) m-amylphenyl-n-methylcarbamate